PDF herunterladen
Synfacts 2005(2): 0190-0190  
DOI: 10.1055/s-2005-916055
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York

Synthesis of (-)-Kendomycin

Contributor(s): Philip Kocienski
III, A. B. Smith*, E. F. Mesaros, E. A. Meyer
University Of Pennsylvania, Philadelphia, USA
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
25. Oktober 2005 (online)

    Lizenzen und Reprints

Significance

The target molecule (isolated from Streptomyces violaceoruber) is an endothelin receptor antagonist and antiosteoporotic agent. It is also active against multiresistant bacteria, including vancomycin-resistant strains.